アジア太平洋の化合物管理市場予測2020-2056

Inkwood Researchが発行した調査報告書(INK20MY107)
◆英語タイトル:ASIA PACIFIC COMPOUND MANAGEMENT MARKET FORECAST 2020-2028
◆商品コード:INK20MY107
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年3月
◆ページ数:103
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アジア太平洋
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥137,500見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥220,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

KEY FINDINGSThe Asia Pacific compound management market is anticipated to be the fastest-growing during the projected period, 2020-2028, recording a CAGR of 14.54%. The Asia Pacific region entails countries like India, Japan, China, and South Korea, which are showing increasing growth prospects in their various realms like drug discovery, increasing R&D, and clinical trials. The use of artificial intelligence in new drug development is one of the significant factors propelling the growth of the market.

MARKET INSIGHTS
The Asia Pacific compound management market analysis encompasses the market assessment of Japan, China, South Korea, India, Australia & New Zealand, Thailand, Indonesia, Vietnam, and the rest of the Asia Pacific. India is significantly placed in the global compound management market. The pharmaceutical industry in India is the third-largest when it comes to volume, and the thirteenth-largest when it comes to value. The rapidly growing old-age population and the increasing prevalence of lifestyle and chronic diseases are opening up the Indian market for many international and local pharmaceutical companies. There has also been a significant increase in the R&D expenditure of the pharmaceutical companies. This is further set to result in increased demands for outsourcing the R&D activities to the CROs.
In South Korea, the increasing focus on developing artificial intelligence (AI) based drug discovery is set to contribute to the market growth prospects of the region. The growing pharmaceutical; market in the Indonesian region is driving its market growth. The developing healthcare system and medical infrastructure make Thailand a popular destination for drug clinical trials, which impacts its market growth positively.

COMPETITIVE INSIGHTS
Some of the well-established companies in the market include LiCONiC Systems, SPT Labtech (name changed from TTP Labtech), TCG Lifesciences Pvt Ltd, Titian Software, Wuxi AppTec, Tecan Trading AG, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. GROWTH IN R&D ACTIVITIES IN PHARMACEUTICAL AND BIOTECH SECTOR
3.2.2. GROWTH IN THE NUMBER OF CLINICAL TRIALS CONDUCTED
3.2.3. BIO BANKING SECTOR PUSHING MARKET GROWTH
3.3. KEY RESTRAINTS
3.3.1. LACK OF SKILLED PROFESSIONALS
3.3.2. COMPOUND MANAGEMENT FACILITIES ARE CAPITAL INTENSIVE
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
4.5. GROWTH STRATEGIES
4.5.1. ORGANIC GROWTH STRATEGIES
4.5.2. INORGANIC GROWTH STRATEGIES
5. MARKET BY PRODUCTS & SERVICES
5.1. PRODUCT
5.1.1. INSTRUMENTS
5.1.1.1. AUTOMATED COMPOUND/SAMPLE STORAGE SYSTEMS MARKET
5.1.1.2. MANUAL COMPOUND/SAMPLE STORAGE SYSTEMS MARKET
5.1.1.3. AUTOMATED LIQUID HANDLING SYSTEMS MARKET
5.1.2. SOFTWARE
5.2. SERVICES
6. MARKET BY SAMPLE TYPE
6.1. CHEMICAL COMPOUNDS
6.2. BIOSAMPLES
7. MARKET BY APPLICATION
7.1. DRUG DISCOVERY
7.2. GENE SYNTHESIS
7.3. BIOBANKING
8. MARKET BY END USER
8.1. PHARMACEUTICAL COMPANIES
8.2. BIOPHARMACEUTICAL COMPANIES
8.3. CONTRACT RESEARCH ORGANISATION
8.4. OTHERS
9. GEOGRAPHICAL ANALYSIS
9.1. ASIA PACIFIC
9.1.1. CHINA
9.1.2. JAPAN
9.1.3. INDIA
9.1.4. SOUTH KOREA
9.1.5. INDONESIA
9.1.6. THAILAND
9.1.7. VIETNAM
9.1.8. AUSTRALIA & NEW ZEALAND
9.1.9. REST OF ASIA PACIFIC
10. COMPANY PROFILES
10.1. AXXAM S.P.A.
10.2. BECKMAN COULTER INC
10.3. BIOASCENT
10.4. BIOSERO INC
10.5. BROOKS LIFE SCIENCES
10.6. EVOTEC
10.7. HAMILTON COMPANY
10.8. ICAGEN INC
10.9. LICONIC SYSTEMS
10.10. TCG LIFESCIENCES PVT LTD
10.11. TECAN TRADING AG
10.12. TITIAN SOFTWARE
10.13. SPT LABTECH (NAME CHANGED FROM TTP LABTECH)
10.14. WUXI APPTEC
10.15. HIGHRES BIOSOLUTIONS



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ アジア太平洋の化合物管理市場予測2020-2056(ASIA PACIFIC COMPOUND MANAGEMENT MARKET FORECAST 2020-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆